Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Oncogene|February 19, 1998
Brca1 and Brca2 expression patterns in mitotic and meiotic cells of miceP E Blackshear, S M Goldsworthy, J F Foley, et al.
Cancer|May 15, 1990
A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatinS Cullinan, C G Moertel, H S Wieand, et al.
American Journal of Clinical Oncology|December 1, 1989
Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancerJ N Ingle, J A Mailliard, D J Schaid, et al.
The American Journal of Pathology|December 10, 1998
Arsenic enhancement of skin neoplasia by chronic stimulation of growth factorsD R Germolec, J Spalding, H S Yu, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Investigational New Drugs|November 1, 1991
Phase II evaluation of menogaril in patients with advanced cervical carcinoma. A collaborative trial of the North Central Cancer Treatment Group and Mayo ClinicH J LONG, H S Wieand, J F Foley, et al.
JAMA|April 12, 1985
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycinS A Cullinan, C G Moertel, T R Fleming, et al.
Cancer|November 11, 1992
A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung carcinomaM H Veeder, J R Jett, J Q Su, et al.
Cancer|May 1, 1993
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment GroupD H Gesme, J R Jett, D D Schreffler, et al.
Cancer|April 1, 1989
Randomized trial to evaluate the addition of tamoxifen to cyclophosphamide, 5-fluorouracil, prednisone adjuvant therapy in premenopausal women with node-positive breast cancerJ N Ingle, L K Everson, H S Wieand, et al.
Pageof 8